| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 05/16/2001 | CN1295619A Salicylate pathway gene and its use for induction of resistance in plants |
| 05/16/2001 | CN1295610A Acidic cleaning composition comprising acidic protease |
| 05/16/2001 | CN1295468A Modified starch coating |
| 05/16/2001 | CN1295460A Polyalkoxy copolymers as lipase inhibitors and their composition |
| 05/16/2001 | CN1295441A Method and apparatus for processing krill hydrolysates |
| 05/16/2001 | CN1295130A Method of utilizing antisense gene in controlling protein and oil content of seed |
| 05/16/2001 | CN1295128A Viral tissue proteinase gene of Chinese bollworm |
| 05/16/2001 | CN1065917C Enzyme method separation process for racemic ketoprofen |
| 05/16/2001 | CN1065916C Polypeptides relating biology synthetic cobalamins and/or cobamides, coding DNA sequence of polypeptides, process for preparing them and use |
| 05/16/2001 | CN1065914C Biosynthesized serine and its related product and process |
| 05/15/2001 | US6232530 Marigold DNA encoding beta-cyclase |
| 05/15/2001 | US6232527 Structure specific endonuclease in dna replication and nucleotide excision repair reactions for gene targeting and production of male sterile plants |
| 05/15/2001 | US6232525 Mutant plants and uses therefor |
| 05/15/2001 | US6232524 Live mouse mutagenesis systems for testing mutagenic agents in vivo |
| 05/15/2001 | US6232459 Synaptojanin isoform |
| 05/15/2001 | US6232457 Recombinant vanadium haloperoxidases and their uses |
| 05/15/2001 | US6232456 Serine protease reagents and methods useful for detecting and treating diseases of the prostate |
| 05/15/2001 | US6232454 Nucleic acid and amino acid sequences and use in diagnosis, treatment, and prevention of cancer and immune disorders |
| 05/15/2001 | US6232448 Immunological materials and methods for detecting dihydropyrimidine dehydrogenase |
| 05/15/2001 | US6232438 Angiotensin converting enzyme inhibitors |
| 05/15/2001 | US6232342 Protease inhibitors |
| 05/15/2001 | US6232305 Substituted amino bicyclic-β-lactam penam and cepham derivatives as cysteine protease inhibitors |
| 05/15/2001 | US6232292 3-dehydroquinate synthase |
| 05/15/2001 | US6232122 Inhibition of gene expression |
| 05/15/2001 | US6232110 Coding sequence for protein phosphatase methylesterase, recombinant DNA molecules and methods |
| 05/15/2001 | US6232109 Plant genes |
| 05/15/2001 | US6232108 Prenylcysteine carboxyl methyltransferase, DNA encoding same, and a method of screening for inhibitors thereof |
| 05/15/2001 | US6232107 Nucleotide sequence coding green fluorescent protein; for use in diagnosis of microorganism infection |
| 05/15/2001 | US6232102 Glucosyltransferase gene gtfe from Amycolatopsis orientalis |
| 05/15/2001 | US6232097 Nucleotide sequences coding enzymatic polypeptide; prevent bacterial infection; wound healing agents; for vaccine development |
| 05/15/2001 | US6232096 Flea serine protease nucleic acid molecules and uses thereof |
| 05/15/2001 | US6232089 CD23 processing enzyme preparation |
| 05/15/2001 | US6232088 Administering hydrolase enzyme; deactivating cellular adhesion molecules |
| 05/15/2001 | US6232077 Genetic engineering and expression; cancer diagnosis |
| 05/15/2001 | US6232071 Tenascin-C nucleic acid ligands |
| 05/15/2001 | US6232070 Pharmacological targeting of mRNA cap formation |
| 05/15/2001 | US6231864 Strategically modified hepatitis B core proteins and their derivatives |
| 05/15/2001 | US6231854 Methioninase formulations and use in diagnostic methods |
| 05/15/2001 | US6231853 Human glutathione peroxidase-6 |
| 05/15/2001 | CA2083948C Glyphosate tolerant plants |
| 05/15/2001 | CA2038352C Heat-resistant .beta.-galactosyltransferase, its production process and its use |
| 05/15/2001 | CA1341230C Amino acid sequence of l-phenylalanine ammonia-lyase, structural gene thereof, novel dna sequence containing same, novel recombinant dna plasmid containing same transformant formed therewith, and process for the production of l-phenylalanine by using same |
| 05/15/2001 | CA1341228C Expression of protein c |
| 05/10/2001 | WO2001032922A2 Methods for detection of a target nucleic acid sequence |
| 05/10/2001 | WO2001032918A1 Specific peptide substrate for human yak1, yak3a, and yak3b and yeast yak1 protein kinases |
| 05/10/2001 | WO2001032907A1 Nucleic acid molecules encoding isopentenyl monophosphate kinase, and methods of use |
| 05/10/2001 | WO2001032904A2 Method for enhancing secretion of beta-lactam compounds |
| 05/10/2001 | WO2001032896A1 Protein expression systems for non-pathogenic <i>kinetoplastidae</i> |
| 05/10/2001 | WO2001032894A1 Cell surface display of proteins by recombinant host cells |
| 05/10/2001 | WO2001032893A1 Recombinant therapeutic fusion proteins |
| 05/10/2001 | WO2001032892A1 Polynucleotide encoding mouse histidine decarboxylase |
| 05/10/2001 | WO2001032891A2 Human lipase |
| 05/10/2001 | WO2001032890A1 L-pantolactone-hydrolase and a method for producing d-pantolactone |
| 05/10/2001 | WO2001032889A1 Murine serine/threonine kinase, yak3 |
| 05/10/2001 | WO2001032888A2 Human transferase molecules |
| 05/10/2001 | WO2001032887A1 Compositions and methods utilizing dna polymerases |
| 05/10/2001 | WO2001032886A2 Starch branching enzymes |
| 05/10/2001 | WO2001032885A2 Human lipase |
| 05/10/2001 | WO2001032876A2 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 05/10/2001 | WO2001032869A1 HUMAN PROTEINS BINDING TO HUMAN TYROSINE KINASE Hck AND GENES ENCODING THE SAME |
| 05/10/2001 | WO2001032858A1 A high throughput screening (hts) method |
| 05/10/2001 | WO2001032849A2 Inhibitors of vegetable cystathionin gamma synthase |
| 05/10/2001 | WO2001032848A1 Mimic cellulose binding domain |
| 05/10/2001 | WO2001032847A1 Novel esterases derived from pseudomonas aeruginosa, its gene and process for production of optically active carboxylic acids using them |
| 05/10/2001 | WO2001032845A2 Methods for the preparation of (lipo)peptide synthetases and (lipo)peptides produced therewith |
| 05/10/2001 | WO2001032844A1 Microtiter plate (mtp) based high throughput screening (hts) assays |
| 05/10/2001 | WO2001032831A2 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 05/10/2001 | WO2001032703A1 Substance capable of controlling the inclusion of exon 10 of the tau gene, and its therapeutic use against tauopathies |
| 05/10/2001 | WO2001032701A1 A new polypeptide - subunit 15 of human f1f0 atp synthase and a polynucleotide encoding the same |
| 05/10/2001 | WO2001032700A1 A new polypeptide - human uracil phosphoribosyl transferase 21 and a polynucleotide encoding the same |
| 05/10/2001 | WO2001032699A1 Novel human udp-glucose: glycoprotein glucosyltransferase and a polynucleotide encoding the same |
| 05/10/2001 | WO2001032691A1 Hcv ns3 protease inhibitors |
| 05/10/2001 | WO2001032690A1 Substituted dipeptides having nos inhibiting activity |
| 05/10/2001 | WO2001032686A2 Arginine kinase |
| 05/10/2001 | WO2001032673A1 Sequences encoding human neoplastic marker |
| 05/10/2001 | WO2001032186A2 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
| 05/10/2001 | WO2001032156A2 Methods for treating fibroproliferative diseases |
| 05/10/2001 | WO2001032126A2 Congenic animal models of non-insulin dependent diabetes mellitus |
| 05/10/2001 | WO2001032009A1 Propagation of human hepatocytes in non-human animals |
| 05/10/2001 | WO2001032008A1 Methods for sexing non-human mammals |
| 05/10/2001 | WO2001003728A3 Gene therapy for enhancing and/or inducing angiogenesis |
| 05/10/2001 | WO2000077207A3 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 05/10/2001 | WO2000060091A3 Method for selecting recombinase variants with altered specificity |
| 05/10/2001 | WO2000060059A3 Alpha-amylase variants |
| 05/10/2001 | US20010001041 Homogenizing a tissue in a nondenaturing aqueous solvent to obtain particles; aqueous solvent extraction; separation of solid and liquid; fractionating and purifying; inhibitors of matrix metalloprotease and angiogenesis; antitumor agents |
| 05/10/2001 | DE19953696A1 Selective non-peptidic proteolytic enzyme analogue useful for the dissolution of plaques and treatment of polypeptide mediated illnesses comprises proteolytic amino acid residues bonded to a carrier molecule |
| 05/10/2001 | DE19953519A1 Inhibitoren der pflanzlichen Cystathionin gamma-Synthase Inhibitors of plant cystathionine gamma-synthase |
| 05/10/2001 | DE19951196A1 Massgeschneiderte Peptidsynthetasen und ihre Verwendung Tailor-made peptide synthetases and their use |
| 05/10/2001 | CA2390017A1 Cell surface display of proteins by recombinant host cells |
| 05/10/2001 | CA2389906A1 Methods for sexing non-human mammals |
| 05/10/2001 | CA2389852A1 Congenic animal models of non-insulin dependent diabetes mellitus |
| 05/10/2001 | CA2389754A1 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 05/10/2001 | CA2389676A1 Substance capable of controlling the inclusion of exon 10 of the tau gene, and its therapeutic use against tauopathies |
| 05/10/2001 | CA2389646A1 Propagation of human hepatocytes in non-human animals |
| 05/10/2001 | CA2389543A1 Hcv ns3 protease inhibitors |
| 05/10/2001 | CA2389390A1 Starch branching enzymes |
| 05/10/2001 | CA2389339A1 Recombinant therapeutic fusion proteins |
| 05/10/2001 | CA2389064A1 L-pantolactone-hydrolase and a method for producing d-pantolactone |
| 05/10/2001 | CA2389062A1 Human protein which binds to human tyrosine kinase hck, and gene encoding the same |
| 05/10/2001 | CA2388982A1 Microtiter plate (mtp) based high throughput screening (hts) assays |